- Investing Ideas
- Global Pharmaceuticals & Biotech Too Big To Fail
Global Pharmaceuticals & Biotech Too Big To Fail
Results
11
Large established companies which pay a dividend.
11 companies
Sanofi
Market Cap: €92.5b
Engages in the research, development, manufacture, and marketing of therapeutic solutions.
SAN
€76.75
7D
1.7%
1Y
-7.0%
Astellas Pharma
Market Cap: JP¥3.9t
Engages in the research, development, manufacture, sale, and supply of pharmaceuticals in Japan and internationally.
4503
JP¥2,196.50
7D
2.4%
1Y
54.4%
Shionogi
Market Cap: JP¥2.5t
Engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan and internationally.
4507
JP¥2,900.00
7D
1.8%
1Y
19.7%
Orion Oyj
Market Cap: €10.6b
Develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, rest of Europe, North America, and internationally.
ORNBV
€76.55
7D
12.7%
1Y
9.8%
Krka d. d
Market Cap: €8.1b
A generic pharmaceutical company, develops, produces, markets, and sells prescription pharmaceuticals, non-prescription products, and animal health products in Slovenia, South-East Europe, East Europe, Central Europe, West Europe, and internationally.
KRKG
€261.00
7D
-1.5%
1Y
33.2%
Kyowa Kirin
Market Cap: JP¥1.4t
Engages in the research, development, manufacturing, and marketing of pharmaceuticals in Japan, the Americas, Europe, Asia, and internationally.
4151
JP¥2,657.00
7D
-0.1%
1Y
7.2%
Ono Pharmaceutical
Market Cap: JP¥1.1t
Produces, purchases, and sells pharmaceuticals and diagnostic reagents worldwide.
4528
JP¥2,397.00
7D
-1.5%
1Y
51.6%
China Resources Sanjiu Medical & Pharmaceutical
Market Cap: CN¥41.6b
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.
000999
CN¥25.00
7D
0.5%
1Y
-21.1%
Santen Pharmaceutical
Market Cap: JP¥650.6b
Engages in the research and development, manufacturing, and marketing of pharmaceuticals and medical devices in Japan, China, Asia, Europe, the Middle East, Africa, and internationally.
4536
JP¥2,022.50
7D
-4.9%
1Y
21.5%
Livzon Pharmaceutical Group
Market Cap: CN¥25.0b
Researches, develops, produces, exports, and sells pharmaceutical products, and active pharmaceutical ingredients (API) and intermediates in the People’s Republic of China and internationally.
000513
CN¥30.89
7D
0.3%
1Y
-29.6%
Apeloa PharmaceuticalLtd
Market Cap: CN¥22.7b
Provides raw materials various pharmaceutical factories in the People’s Republic of China and internationally.
000739
CN¥20.13
7D
5.4%
1Y
32.1%